Literature DB >> 34351882

Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings - Barnstable County, Massachusetts, July 2021.

Catherine M Brown, Johanna Vostok, Hillary Johnson, Meagan Burns, Radhika Gharpure, Samira Sami, Rebecca T Sabo, Noemi Hall, Anne Foreman, Petra L Schubert, Glen R Gallagher, Timelia Fink, Lawrence C Madoff, Stacey B Gabriel, Bronwyn MacInnis, Daniel J Park, Katherine J Siddle, Vaira Harik, Deirdre Arvidson, Taylor Brock-Fisher, Molly Dunn, Amanda Kearns, A Scott Laney.   

Abstract

During July 2021, 469 cases of COVID-19 associated with multiple summer events and large public gatherings in a town in Barnstable County, Massachusetts, were identified among Massachusetts residents; vaccination coverage among eligible Massachusetts residents was 69%. Approximately three quarters (346; 74%) of cases occurred in fully vaccinated persons (those who had completed a 2-dose course of mRNA vaccine [Pfizer-BioNTech or Moderna] or had received a single dose of Janssen [Johnson & Johnson] vaccine ≥14 days before exposure). Genomic sequencing of specimens from 133 patients identified the B.1.617.2 (Delta) variant of SARS-CoV-2, the virus that causes COVID-19, in 119 (89%) and the Delta AY.3 sublineage in one (1%). Overall, 274 (79%) vaccinated patients with breakthrough infection were symptomatic. Among five COVID-19 patients who were hospitalized, four were fully vaccinated; no deaths were reported. Real-time reverse transcription-polymerase chain reaction (RT-PCR) cycle threshold (Ct) values in specimens from 127 vaccinated persons with breakthrough cases were similar to those from 84 persons who were unvaccinated, not fully vaccinated, or whose vaccination status was unknown (median = 22.77 and 21.54, respectively). The Delta variant of SARS-CoV-2 is highly transmissible (1); vaccination is the most important strategy to prevent severe illness and death. On July 27, CDC recommended that all persons, including those who are fully vaccinated, should wear masks in indoor public settings in areas where COVID-19 transmission is high or substantial.* Findings from this investigation suggest that even jurisdictions without substantial or high COVID-19 transmission might consider expanding prevention strategies, including masking in indoor public settings regardless of vaccination status, given the potential risk of infection during attendance at large public gatherings that include travelers from many areas with differing levels of transmission.

Entities:  

Year:  2021        PMID: 34351882     DOI: 10.15585/mmwr.mm7031e2

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  185 in total

1.  Experiences with Public Health Recommendations for COVID-19: A Qualitative Study of Diverse Mothers with Young Children in the United States.

Authors:  Katherine R Arlinghaus; Derek Hersch; Dianne Neumark-Sztainer; Katie A Loth
Journal:  J Commun Healthc       Date:  2022-02-11

2.  Highly conserved s2m element of SARS-CoV-2 dimerizes via a kissing complex and interacts with host miRNA-1307-3p.

Authors:  Joshua A Imperatore; Caylee L Cunningham; Kendy A Pellegrene; Robert G Brinson; John P Marino; Jeffrey D Evanseck; Mihaela Rita Mihailescu
Journal:  Nucleic Acids Res       Date:  2022-01-25       Impact factor: 16.971

3.  Excess Deaths During the COVID-19 Economic Downturn.

Authors:  José A Pagán
Journal:  Am J Public Health       Date:  2021-10-28       Impact factor: 9.308

4.  Attitudes about COVID-19 Testing among Black Adults in the United States.

Authors:  Sarah Schaffer DeRoo; Rachel G Torres; Sivan Ben-Maimon; Jennifer Jiggetts; Linda Y Fu
Journal:  Ethn Dis       Date:  2021-10-21       Impact factor: 1.847

5.  Mucosal administration of a live attenuated recombinant COVID-19 vaccine protects nonhuman primates from SARS-CoV-2.

Authors:  Mariana F Tioni; Robert Jordan; Angie Silva Pena; Aditya Garg; Danlu Wu; Shannon I Phan; Christopher M Weiss; Xing Cheng; Jack Greenhouse; Tatyana Orekov; Daniel Valentin; Swagata Kar; Laurent Pessaint; Hanne Andersen; Christopher C Stobart; Melissa H Bloodworth; R Stokes Peebles; Yang Liu; Xuping Xie; Pei-Yong Shi; Martin L Moore; Roderick S Tang
Journal:  NPJ Vaccines       Date:  2022-07-29       Impact factor: 9.399

6.  Relative effectiveness of booster vs. 2-dose mRNA Covid-19 vaccination in the Veterans Health Administration: Self-controlled risk interval analysis.

Authors:  Caroline Korves; Hector S Izurieta; Jeremy Smith; Gabrielle M Zwain; Ethan I Powell; Abirami Balajee; Kathryn M Ryder; Yinong Young-Xu
Journal:  Vaccine       Date:  2022-06-21       Impact factor: 4.169

7.  Intranasal immunization with avian paramyxovirus type 3 expressing SARS-CoV-2 spike protein protects hamsters against SARS-CoV-2.

Authors:  Hong-Su Park; Yumiko Matsuoka; Cindy Luongo; Lijuan Yang; Celia Santos; Xueqiao Liu; Laura R H Ahlers; Ian N Moore; Sharmin Afroz; Reed F Johnson; Bernard A P Lafont; David W Dorward; Elizabeth R Fischer; Craig Martens; Siba K Samal; Shirin Munir; Ursula J Buchholz; Cyril Le Nouën
Journal:  NPJ Vaccines       Date:  2022-06-28       Impact factor: 9.399

Review 8.  Potential of Endogenous Oxytocin in Endocrine Treatment and Prevention of COVID-19.

Authors:  Stephani C Wang; Fengmin Zhang; Hui Zhu; Haipeng Yang; Yang Liu; Ping Wang; Vladimir Parpura; Yu-Feng Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-03       Impact factor: 6.055

9.  Time-Dependent Increase in Susceptibility and Severity of Secondary Bacterial Infections During SARS-CoV-2.

Authors:  Amanda P Smith; Evan P Williams; Taylor R Plunkett; Muneeswaran Selvaraj; Lindey C Lane; Lillian Zalduondo; Yi Xue; Peter Vogel; Rudragouda Channappanavar; Colleen B Jonsson; Amber M Smith
Journal:  Front Immunol       Date:  2022-05-12       Impact factor: 8.786

10.  Vaccination of COVID-19 convalescent plasma donors increases binding and neutralizing antibodies against SARS-CoV-2 variants.

Authors:  Clara Di Germanio; Graham Simmons; Chloe Thorbrogger; Rachel Martinelli; Mars Stone; Thomas Gniadek; Michael P Busch
Journal:  Transfusion       Date:  2022-02-13       Impact factor: 3.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.